EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma

Roberto Iezzi, Alessandro Posa, Iacopo Valente, Andrea Contegiacomo, Maria Assunta Zocco, Maurizio Pompili, Brigida Eleonora Annicchiarico, Francesca Romana Ponziani, Michele Basso, Shraga Nahum Goldberg, Felice Giuliante, Antonio Gasbarrini und 2 weitere

La radiologia medica · 2024

DOI: 10.1007/s11547-024-01805-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift La radiologia medica, 2024. Verfasst von Roberto Iezzi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Imaging, Oncologic Radiotherapy, and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.Go A. Gemelli 8, 0…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Cone-Beam Computed Tomography, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università Cattolica del Sacro Cuore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Combined treatment of ablation and chemoembolization for hepatocellular carcinoma represents a promising therapy to increase treatment efficacy and improve patient survival. The “hug sign” is a recently introduced radiological sign consisting in deposition of beads/contrast agent during transarterial chemoembolization in the hyperemic area surrounding the post-ablation volume, seen during intraprocedural unenhanced cone-beam CT, that may indicate intraprocedural success. Aim of our retrospective study was to analyze the usefulness of the “hug sign” at the intraprocedural unenhanced cone-beam CT as an early predictor of response to combined treatment, based on the hug sign angle. Materials and methods Between January 2017 and September 2021 all patients with hepatocellular carcinoma which underwent a combined treatment of thermal ablation followed by chemoembolization were enrolled. All treated patients underwent immediate post-procedural unenhanced cone-beam CT to evaluate the deposition of contrast agent, lipiodol or radiopaque beads and to assess the percentage of coverage of the ablated area with the contrast agent (hug sign angle). Patients with missing pre-procedural, intra-procedural and/or post-procedural data/imaging, or with poor-quality post-procedural cone-beam CT images were excluded.

Results

128 patients (mean age, 69.3 years ± 1.1 [standard deviation]; 87 men) were evaluated. Our study evidenced that 84.4% (81/85) of patients with a hug sign angle of 360° had no residual tumor at the first 1-/3-months follow-up examination. A hug sign angle of 360° also showed to be an independent protective factor against residual tumor at multivariate analysis.

Conclusion

Unenhanced cone-beam CT performed at the end of a combined treatment with ablation plus chemoembolization can effectively predict an early treatment response on radiological images, when a hug sign angle of 360° was detected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularCone-Beam Computed TomographyChemoembolization, TherapeuticContrast MediaHumansMaleFemaleRetrospective StudiesAgedMiddle AgedTreatment OutcomeCombined Modality TherapyPredictive Value of TestsEthiodized Oil

Stichwörter der Autor:innen

AblationChemoembolizationCombined treatmentHepatocellular carcinomaResponse prediction

Substanzen

Contrast MediaEthiodized Oil

Autor:innen und Institutionen

  • Department of Diagnostic Imaging, Oncologic Radiotherapy, and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.Go A. Gemelli 8, 00168, Rome, Italy. roberto.iezzi.md@gmail.com.
  • Università Cattolica del Sacro Cuore, Rome, Italy. roberto.iezzi.md@gmail.com.
  • U.O.C. Radiologia d'Urgenza e Interventistica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 8, 00168, Rome, Ital…
  • Department of Diagnostic Imaging, Oncologic Radiotherapy, and Hematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.Go A. Gemelli 8, 00168, Rome, Italy.
  • Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Università Cattolica del Sacro Cuore, Rome, Italy.

Förderung

  • Università Cattolica del Sacro Cuore

Zitieren

APA

Iezzi, R., Posa, A., Valente, I., Contegiacomo, A., Zocco, M. A., Pompili, M., Annicchiarico, B. E., Ponziani, F. R., Basso, M., Goldberg, S. N., Giuliante, F., Gasbarrini, A., Sala, E., & HepatoCatt Study Group (2024). Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma. La radiologia medica. https://doi.org/10.1007/s11547-024-01805-y

Vancouver

Iezzi R, Posa A, Valente I, Contegiacomo A, Zocco MA, Pompili M, et al. Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma. La radiologia medica. 2024. doi:10.1007/s11547-024-01805-y

BibTeX
@article{Iezzi2024,
  author = {Iezzi, Roberto and Posa, Alessandro and Valente, Iacopo and Contegiacomo, Andrea and Zocco, Maria Assunta and Pompili, Maurizio and Annicchiarico, Brigida Eleonora and Ponziani, Francesca Romana and Basso, Michele and Goldberg, Shraga Nahum and Giuliante, Felice and Gasbarrini, Antonio and Sala, Evis and HepatoCatt Study Group, HepatoCatt Study Group},
  title = {Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma},
  journal = {La radiologia medica},
  year = {2024},
  doi = {10.1007/s11547-024-01805-y}
}
Kostenlos starten →